Tryptophan metabolism as a common therapeutic target in cancer, neurodegeneration and beyond

UCSF Chimera—A visualization system for exploratory research and analysis

Pettersen, E. F., Goddard, T. D., Huang, C. C., Couch, G. S., Greenblatt, D. M., Meng, E. C., & Ferrin, T. E. (2004) · Journal of Computational Chemistry · doi:10.1002/jcc.20084 · Cited by 45,260 · see citing works

Tissue-based map of the human proteome

Uhlén, M., Fagerberg, L., Hallström, B. M., Lindskog, C., Oksvold, P., Mardinoglu, A., Sivertsson, Å., Kampf, C., Sjöstedt, E., Asplund, A., et al. (2015) · Science · doi:10.1126/science.1260419 · Cited by 15,286 · see citing works

Tryptophan catabolites from microbiota engage aryl hydrocarbon receptor and balance mucosal reactivity via interleukin-22

Zelante, T., Iannitti, R. G., Cunha, C., De Luca, A., Giovannini, G., Pieraccini, G., Zecchi, R., D’Angelo, C., Massi-Benedetti, C., Fallarino, F., et al. (2013) · Immunity · doi:10.1016/j.immuni.2013.08.003 · Cited by 2,614 · see citing works

Prevention of Allogeneic Fetal Rejection by Tryptophan Catabolism

Munn, D. H., Zhou, M., Attwood, J. T., Bondarev, I. E., Conway, S. J., Marshall, B., Brown, C. C., & Mellor, A. L. (1998) · Science · doi:10.1126/science.281.5380.1191 · Cited by 2,589 · see citing works

Ido expression by dendritic cells: tolerance and tryptophan catabolism

Mellor, A. L., & Munn, D. H. (2004) · Nature Reviews Immunology · doi:10.1038/nri1457 · Cited by 2,341 · see citing works

Evidence for a tumoral immune resistance mechanism based on tryptophan degradation by indoleamine 2,3-dioxygenase

Uyttenhove, C., Pilotte, L., Théate, I., Stroobant, V., Colau, D., Parmentier, N., Boon, T., & Van den Eynde, B. J. (2003) · Nature Medicine · doi:10.1038/nm934 · Cited by 2,305 · see citing works

An endogenous tumour-promoting ligand of the human aryl hydrocarbon receptor

Opitz, C. A., Litzenburger, U. M., Sahm, F., Ott, M., Tritschler, I., Trump, S., Schumacher, T., Jestaedt, L., Schrenk, D., Weller, M., et al. (2011) · Nature · doi:10.1038/nature10491 · Cited by 1,898 · see citing works

Immunity to fungal infections

Romani, L. (2011) · Nature Reviews Immunology · doi:10.1038/nri2939 · Cited by 1,793 · see citing works

Inhibition of  T Cell Proliferation by Macrophage Tryptophan Catabolism

Munn, D., Shafizadeh, E., Attwood, J., Bondarev, I., Pashine, A., & Mellor, A. (1999) · Journal of Experimental Medicine · doi:10.1084/jem.189.9.1363 · Cited by 1,721 · see citing works

An Interaction between Kynurenine and the Aryl Hydrocarbon Receptor Can Generate Regulatory T Cells

Mezrich, J. D., Fechner, J. H., Zhang, X., Johnson, B. P., Burlingham, W. J., & Bradfield, C. A. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.0903670 · Cited by 1,613 · see citing works

Type I interferons and microbial metabolites of tryptophan modulate astrocyte activity and central nervous system inflammation via the aryl hydrocarbon receptor

Rothhammer, V., Mascanfroni, I. D., Bunse, L., Takenaka, M. C., Kenison, J. E., Mayo, L., Chao, C.-C., Patel, B., Yan, R., Blain, M., et al. (2016) · Nature Medicine · doi:10.1038/nm.4106 · Cited by 1,559 · see citing works

Kynurenines in the mammalian brain: when physiology meets pathology

Schwarcz, R., Bruno, J. P., Muchowski, P. J., & Wu, H.-Q. (2012) · Nature Reviews Neuroscience · doi:10.1038/nrn3257 · Cited by 1,530 · see citing works

CARD9 impacts colitis by altering gut microbiota metabolism of tryptophan into aryl hydrocarbon receptor ligands

Lamas, B., Richard, M. L., Leducq, V., Pham, H.-P., Michel, M.-L., Da Costa, G., Bridonneau, C., Jegou, S., Hoffmann, T. W., Natividad, J. M., et al. (2016) · Nature Medicine · doi:10.1038/nm.4102 · Cited by 1,482 · see citing works

Kynurenines: Tryptophan’s metabolites in exercise, inflammation, and mental health

Cervenka, I., Agudelo, L. Z., & Ruas, J. L. (2017) · Science · doi:10.1126/science.aaf9794 · Cited by 1,382 · see citing works

Modulation of tryptophan catabolism by regulatory T cells

Fallarino, F., Grohmann, U., Hwang, K. W., Orabona, C., Vacca, C., Bianchi, R., Belladonna, M. L., Fioretti, M. C., Alegre, M., & Puccetti, P. (2003) · Nature Immunology · doi:10.1038/ni1003 · Cited by 1,375 · see citing works

Impact of the Gut Microbiota on Intestinal Immunity Mediated by Tryptophan Metabolism

Gao, J., Xu, K., Liu, H., Liu, G., Bai, M., Peng, C., Li, T., & Yin, Y. (2018) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2018.00013 · Cited by 1,313 · see citing works

GCN2 Kinase in T Cells Mediates Proliferative Arrest and Anergy Induction in Response to Indoleamine 2,3-Dioxygenase

Munn, D. H., Sharma, M. D., Baban, B., Harding, H. P., Zhang, Y., Ron, D., & Mellor, A. L. (2005) · Immunity · doi:10.1016/j.immuni.2005.03.013 · Cited by 1,275 · see citing works

NAD ⁺ repletion improves mitochondrial and stem cell function and enhances life span in mice

Zhang, H., Ryu, D., Wu, Y., Gariani, K., Wang, X., Luan, P., D’Amico, D., Ropelle, E. R., Lutolf, M. P., Aebersold, R., et al. (2016) · Science · doi:10.1126/science.aaf2693 · Cited by 1,255 · see citing works

CTLA-4–Ig regulates tryptophan catabolism in vivo

Grohmann, U., Orabona, C., Fallarino, F., Vacca, C., Calcinaro, F., Falorni, A., Candeloro, P., Belladonna, M. L., Bianchi, R., Fioretti, M. C., et al. (2002) · Nature Immunology · doi:10.1038/ni846 · Cited by 1,160 · see citing works

Ageing, neurodegeneration and brain rejuvenation

Wyss-Coray, T. (2016) · Nature · doi:10.1038/nature20411 · Cited by 1,147 · see citing works

Tryptophan-derived Catabolites Are Responsible for Inhibition of T and Natural Killer Cell Proliferation Induced by Indoleamine 2,3-Dioxygenase

Frumento, G., Rotondo, R., Tonetti, M., Damonte, G., Benatti, U., & Ferrara, G. B. (2002) · The Journal of Experimental Medicine · doi:10.1084/jem.20020121 · Cited by 1,133 · see citing works

Inhibition of indoleamine 2,3-dioxygenase, an immunoregulatory target of the cancer suppression gene Bin1, potentiates cancer chemotherapy

Muller, A. J., DuHadaway, J. B., Donover, P. S., Sutanto-Ward, E., & Prendergast, G. C. (2005) · Nature Medicine · doi:10.1038/nm1196 · Cited by 1,064 · see citing works

Indole as an intercellular signal in microbial communities

Lee, J.-H., & Lee, J. (2010) · FEMS Microbiology Reviews · doi:10.1111/j.1574-6976.2009.00204.x · Cited by 1,059 · see citing works

IDO in the Tumor Microenvironment: Inflammation, Counter-Regulation, and Tolerance

Munn, D. H., & Mellor, A. L. (2016) · Trends in Immunology · doi:10.1016/j.it.2016.01.002 · Cited by 1,054 · see citing works

Microglial control of astrocytes in response to microbial metabolites

Rothhammer, V., Borucki, D. M., Tjon, E. C., Takenaka, M. C., Chao, C.-C., Ardura-Fabregat, A., de Lima, K. A., Gutiérrez-Vázquez, C., Hewson, P., Staszewski, O., et al. (2018) · Nature · doi:10.1038/s41586-018-0119-x · Cited by 1,051 · see citing works

The Combined Effects of Tryptophan Starvation and Tryptophan Catabolites Down-Regulate T Cell Receptor ζ-Chain and Induce a Regulatory Phenotype in Naive T Cells

Fallarino, F., Grohmann, U., You, S., McGrath, B. C., Cavener, D. R., Vacca, C., Orabona, C., Bianchi, R., Belladonna, M. L., Volpi, C., et al. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.176.11.6752 · Cited by 1,042 · see citing works

Monitoring immune-checkpoint blockade: response evaluation and biomarker development

Nishino, M., Ramaiya, N. H., Hatabu, H., & Hodi, F. S. (2017) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2017.88 · Cited by 1,023 · see citing works

T cell apoptosis by tryptophan catabolism

Fallarino, F., Grohmann, U., Vacca, C., Bianchi, R., Orabona, C., Spreca, A., Fioretti, M. C., & Puccetti, P. (2002) · Cell Death & Differentiation · doi:10.1038/sj.cdd.4401073 · Cited by 1,022 · see citing works

Inhibition of Allogeneic T Cell Proliferation by Indoleamine 2,3-Dioxygenase–expressing Dendritic Cells

Terness, P., Bauer, T. M., Röse, L., Dufter, C., Watzlik, A., Simon, H., & Opelz, G. (2002) · The Journal of Experimental Medicine · doi:10.1084/jem.20020052 · Cited by 939 · see citing works

The aryl hydrocarbon receptor: multitasking in the immune system

Stockinger, B., Meglio, P. D., Gialitakis, M., & Duarte, J. H. (2014) · Annual Review of Immunology · doi:10.1146/annurev-immunol-032713-120245 · Cited by 909 · see citing works

Interferon gamma blocks the growth of Toxoplasma gondii in human fibroblasts by inducing the host cells to degrade tryptophan.

Pfefferkorn, E. (1984) · Proceedings of the National Academy of Sciences of the United States of America · doi:10.1073/pnas.81.3.908 · Cited by 870 · see citing works

Plasmacytoid dendritic cells from mouse tumor-draining lymph nodes directly activate mature Tregs via indoleamine 2,3-dioxygenase

Sharma, M. D., Baban, B., Chandler, P., Hou, D., Singh, N., Yagita∥, H., Azuma, M., Blazar, B. R., Mellor, A. L., & Munn, D. H. (2007) · Journal of Clinical Investigation · doi:10.1172/jci31911 · Cited by 791 · see citing works

Kynurenine pathway metabolism and the microbiota-gut-brain axis

Kennedy, P. J., Cryan, J. F., Dinan, T. G., & Clarke, G. (2017) · Neuropharmacology · doi:10.1016/j.neuropharm.2016.07.002 · Cited by 724 · see citing works

Tryptophan Catabolism in Cancer: Beyond IDO and Tryptophan Depletion

Platten, M., Wick, W., & den Eynde, B. J. V. (2012) · Cancer Research · doi:10.1158/0008-5472.can-12-0569 · Cited by 708 · see citing works

Aryl hydrocarbon receptor negatively regulates dendritic cell immunogenicity via a kynurenine-dependent mechanism

Nguyen, N. T., Kimura, A., Nakahama, T., Chinen, I., Masuda, K., Nohara, K., Fujii‐Kuriyama, Y., & Kishimoto, T. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1014465107 · Cited by 687 · see citing works

Aryl hydrocarbon receptor control of a disease tolerance defence pathway

Bessede, A., Gargaro, M., Pallotta, M. T., Matino, D., Servillo, G., Brunacci, C., Bicciato, S., Mazza, E. M. C., Macchiarulo, A., Vacca, C., et al. (2014) · Nature · doi:10.1038/nature13323 · Cited by 676 · see citing works

The NAD metabolome — a key determinant of cancer cell biology

Chiarugi, A., Dölle, C., Felici, R., & Ziegler, M. (2012) · Nature reviews. Cancer · doi:10.1038/nrc3340 · Cited by 645 · see citing works

Indoleamine 2,3-dioxygenase is a critical resistance mechanism in antitumor T cell immunotherapy targeting CTLA-4

Holmgaard, R., Zamarin, D., Munn, D. H., Wolchok, J. D., & Allison, J. P. (2013) · The Journal of Experimental Medicine · doi:10.1084/jem.20130066 · Cited by 633 · see citing works

Kynurenic Acid Is a Potent Endogenous Aryl Hydrocarbon Receptor Ligand that Synergistically Induces Interleukin-6 in the Presence of Inflammatory Signaling

DiNatale, B. C., Murray, I. A., Schroeder, J. C., Flaveny, C. A., Lahoti, T. S., Laurenzana, E. M., Omiecinski, C. J., & Perdew, G. H. (2010) · Toxicological Sciences · doi:10.1093/toxsci/kfq024 · Cited by 631 · see citing works

Prognostic value of indoleamine 2,3-dioxygenase expression in colorectal cancer: effect on tumor-infiltrating T cells

Brandacher, G., Perathoner, A., Ladurner, R., Schneeberger, S., Obrist, P., Winkler, C., Werner, E. R., Werner-Felmayer, G., Weiss, H. G., G√∂bel, G., et al. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-1966 · Cited by 614 · see citing works

Inhibition of Indoleamine 2,3-Dioxygenase in Dendritic Cells by Stereoisomers of 1-Methyl-Tryptophan Correlates with Antitumor Responses

Hou, D., Muller, A. J., Sharma, M. D., DuHadaway, J. B., Banerjee, T., Johnson, M., Mellor, A. L., Prendergast, G. C., & Munn, D. H. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-2925 · Cited by 586 · see citing works

Reversal of tumoral immune resistance by inhibition of tryptophan 2,3-dioxygenase

Pilotte, L., Larrieu, P., Stroobant, V., Colau, D., Dolušić, E., Frédérick, R., Plaen, E. D., Uyttenhove, C., Wouters, J., Masereel, B., et al. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1113873109 · Cited by 576 · see citing works

Discovery of IDO1 Inhibitors: From Bench to Bedside

Prendergast, G. C., Malachowski, W. P., DuHadaway, J. B., & Muller, A. J. (2017) · Cancer Research · doi:10.1158/0008-5472.can-17-2285 · Cited by 563 · see citing works

Tumor-repopulating cells induce PD-1 expression in CD8(+) T cells by transferring kynurenine and AhR activation

Liu, Y., Liang, X., Dong, W., Fang, Y., Lv, J., Zhang, T., Fiskesund, R., Xie, J., Liu, J., Yin, X., et al. (2018) · Cancer Cell · doi:10.1016/j.ccell.2018.02.005 · Cited by 535 · see citing works

Tryptophan metabolism, from nutrition to potential therapeutic applications

Floc'h, N. L., Otten, W., & Merlot, E. (2011) · Amino Acids · doi:10.1007/s00726-010-0752-7 · Cited by 529 · see citing works

Tryptophan Catabolism by Indoleamine 2,3-Dioxygenase 1 Alters the Balance of T H 17 to Regulatory T Cells in HIV Disease

Favre, D., Mold, J. E., Hunt, P. W., Kanwar, B., Loke, P., Seu, L., Barbour, J. D., Lowe, M. M., Jayawardene, A., Aweeka, F. T., et al. (2010) · Science Translational Medicine · doi:10.1126/scitranslmed.3000632 · Cited by 526 · see citing works

Imatinib potentiates antitumor T cell responses in gastrointestinal stromal tumor through the inhibition of Ido

Balachandran, V. P., Cavnar, M. J., Zeng, S., Bamboat, Z. M., Ocuin, L. M., Obaid, H., Sorenson, E. C., Popow, R., Ariyan, C. E., Rossi, F., et al. (2011) · Nature Medicine · doi:10.1038/nm.2438 · Cited by 523 · see citing works

Kynurenine 3-Monooxygenase Inhibition in Blood Ameliorates Neurodegeneration

Zwilling, D., Huang, S., Sathyasaikumar, K. V., Notarangelo, F. M., Guidetti, P., Wu, H., Lee, J. H., Truong, J. K., Andrews-Zwilling, Y. S., Hsieh, E., et al. (2011) · Cell · doi:10.1016/j.cell.2011.05.020 · Cited by 519 · see citing works

NAD(+) in aging: molecular mechanisms and translational implications

Fang, E. F., Lautrup, S., Hou, Y., Demarest, T. G., Croteau, D. L., Mattson, M. P., & Bohr, V. A. (2017) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2017.08.001 · Cited by 501 · see citing works

Expression of indoleamine 2,3-dioxygenase and production of quinolinic acid by human microglia, astrocytes, and neurons

Guillemin, G. J., Smythe, G., Takikawa, O., & Brew, B. J. (2005) · Glia · doi:10.1002/glia.20090 · Cited by 497 · see citing works

Indoleamine 2,3-dioxygenase pathways of pathogenic inflammation and immune escape in cancer

Prendergast, G. C., Smith, C., Thomas, S., Mandik‐Nayak, L., Laury‐Kleintop, L. D., Metz, R. A., & Muller, A. J. (2014) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-014-1549-4 · Cited by 484 · see citing works

Kynurenic acid levels are elevated in the cerebrospinal fluid of patients with schizophrenia.

Erhardt, S., Blennow, K., Nordin, C., Skogh, E., Lindström, L., & Engberg, G. (2001) · Neuroscience Letters · doi:10.1016/s0304-3940(01)02242-x · Cited by 478 · see citing works

Mechanism of interferon-gamma action. Characterization of indoleamine 2,3-dioxygenase in cultured human cells induced by interferon-gamma and evaluation of the enzyme-mediated tryptophan degradation in its anticellular activity.

Takikawa, O., Kuroiwa, T., Yamazaki, F., & Kido, R. (1988) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)77982-4 · Cited by 472 · see citing works

Cutting Edge: Induced Indoleamine 2,3 Dioxygenase Expression in Dendritic Cell Subsets Suppresses T Cell Clonal Expansion

Mellor, A. L., Baban, B., Chandler, P., Marshall, B., Jhaver, K. G., Hansen, A. M., Koni, P. A., Iwashima, M., & Munn, D. H. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.171.4.1652 · Cited by 457 · see citing works

The Indoleamine 2,3-Dioxygenase Pathway Is Essential for Human Plasmacytoid Dendritic Cell-Induced Adaptive T Regulatory Cell Generation

Chen, W., Liang, X., Peterson, A. J., Munn, D. H., & Blazar, B. R. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.181.8.5396 · Cited by 453 · see citing works

Kynurenine is an endothelium-derived relaxing factor produced during inflammation

Wang, Y., Liu, H., McKenzie, G. A., Witting, P. K., Stasch, J., Hahn, M. G., Changsirivathanathamrong, D., Wu, B. J., Ball, H. J., Thomas, S. R., et al. (2010) · Nature Medicine · doi:10.1038/nm.2092 · Cited by 446 · see citing works

Tryptophan deprivation sensitizes activated T cells to apoptosis prior to cell division

Lee, G. K., Park, H. J., MacLeod, M. K. L., Chandler, P., Munn, D. H., & Mellor, A. L. (2002) · Immunology · doi:10.1046/j.1365-2567.2002.01526.x · Cited by 433 · see citing works

An endogenous aryl hydrocarbon receptor ligand acts on dendritic cells and T cells to suppress experimental autoimmune encephalomyelitis

Quintana, F. J., Murugaiyan, G., Farez, M., Mitsdoerffer, M., Tukpah, A.-M. C., Burns, E. J., & Weiner, H. L. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1009201107 · Cited by 430 · see citing works

Treatment of Autoimmune Neuroinflammation with a Synthetic Tryptophan Metabolite

Platten, M., Ho, P. P.-K., Youssef, S., da Fontoura, P. P., Garren, H., Hur, E. M., Gupta, R. K., Lee, L. Y., Kidd, B. A., Robinson, W. H., et al. (2005) · Science · doi:10.1126/science.1117634 · Cited by 427 · see citing works

The kynurenine pathway and the brain: challenges, controversies and promises

Schwarcz, R., & Stone, T. (2016) · Neuropharmacology · doi:10.1016/j.neuropharm.2016.08.003 · Cited by 426 · see citing works

Inhibitors of indoleamine-2,3-dioxygenase for cancer therapy: can we see the wood for the trees?

Löb, S., Königsrainer, A., Rammensee, H., Opelz, G., & Terness, P. (2009) · Nature reviews. Cancer · doi:10.1038/nrc2639 · Cited by 421 · see citing works

The tryptophan catabolite l-kynurenine inhibits the surface expression of NKp46- and NKG2D-activating receptors and regulates NK-cell function

Chiesa, M. D., Carlomagno, S., Frumento, G., Balsamo, M., Cantoni, C., Conte, R., Moretta, L., Moretta, A., & Vitale, M. (2006) · Blood · doi:10.1182/blood-2006-03-006700 · Cited by 402 · see citing works

Use of PD-1 Targeting, Macrophage Infiltration, and IDO Pathway Activation in Sarcomas

Toulmonde, M., Penel, N., Adam, J., Chevreau, C., Blay, J., Cesne, A. L., Bompas, E., Piperno-Neumann, S., Cousin, S., Grellety, T., et al. (2017) · JAMA Oncology · doi:10.1001/jamaoncol.2017.1617 · Cited by 402 · see citing works

Modulation of tryptophan catabolism by human leukemic cells results in the conversion of CD25− into CD25+ T regulatory cells

Curti, A., Pandolfi, S., Valzasina, B., Aluigi, M., Isidori, A., Ferri, E., Salvestrini, V., Bonanno, G., Rutella, S., Durelli, I., et al. (2006) · Blood · doi:10.1182/blood-2006-07-036863 · Cited by 396 · see citing works

Recent evidence for an expanded role of the kynurenine pathway of tryptophan metabolism in neurological diseases

Lovelace, M. D., Varney, B., Sundaram, G., Lennon, M. J., Lim, C. K., Jacobs, K., Guillemin, G. J., & Brew, B. J. (2017) · Neuropharmacology · doi:10.1016/j.neuropharm.2016.03.024 · Cited by 393 · see citing works

AhR sensing of bacterial pigments regulates antibacterial defence

Moura‐Alves, P., Fae, K. C., Houthuys, E., Dorhoi, A., Kreuchwig, A., Furkert, J., Barison, N., Diehl, A., Munder, A., Constant, P., et al. (2014) · Nature · doi:10.1038/nature13684 · Cited by 370 · see citing works

Extensive Profiling of the Expression of the Indoleamine 2,3-Dioxygenase 1 Protein in Normal and Tumoral Human Tissues

Théate, I., van Baren, N., Pilotte, L., Moulin, P., Larrieu, P., Renauld, J., Hervé, C., Gutierrez-Roelens, I., Marbaix, É., Sempoux, C. L., et al. (2014) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-14-0137 · Cited by 366 · see citing works

IDO Upregulates Regulatory T Cells via Tryptophan Catabolite and Suppresses Encephalitogenic T Cell Responses in Experimental Autoimmune Encephalomyelitis

Yan, Y., Zhang, G., Gran, B., Fallarino, F., Yu, S., Li, H., Cullimore, M. L., Rostami, A. M., & Xu, H. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.1001628 · Cited by 360 · see citing works

Tryptophan Biosynthesis Protects Mycobacteria from CD4 T-Cell-Mediated Killing

Zhang, Y. J., Reddy, M. C., Ioerger, T. R., Rothchild, A. C., Dartois, V., Schuster, B. M., Trauner, A., Wallis, D., Galaviz, S., Huttenhower, C., et al. (2013) · Cell · doi:10.1016/j.cell.2013.10.045 · Cited by 351 · see citing works

An expanding range of targets for kynurenine metabolites of tryptophan

Stone, T. W., Stoy, N. S., & Darlington, L. G. (2012) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2012.09.006 · Cited by 344 · see citing works

Cancer Immunotherapy by Targeting IDO1/TDO and Their Downstream Effectors

Platten, M., Doeberitz, N. V. K., Oezen, I., Wick, W., & Ochs, K. (2015) · Frontiers in Immunology · doi:10.3389/fimmu.2014.00673 · Cited by 342 · see citing works

Tryptophan depletion as a mechanism of gamma interferon-mediated chlamydial persistence

Beatty, W. L., Belanger, T. A., Desai, A. A., Morrison, R. P., & Byrne, G. I. (1994) · Infection and Immunity · doi:10.1128/iai.62.9.3705-3711.1994 · Cited by 338 · see citing works

Aryl Hydrocarbon Receptor Control of Adaptive Immunity

Quintana, F. J., & Sherr, D. H. (2013) · Pharmacological Reviews · doi:10.1124/pr.113.007823 · Cited by 336 · see citing works

STING Promotes the Growth of Tumors Characterized by Low Antigenicity via IDO Activation

Lemos, H. D. P., Mohamed, E. T., Huang, L., Ou, R., Pacholczyk, G. A., Arbab, A. S., Munn, D. H., & Mellor, A. L. (2016) · Cancer Research · doi:10.1158/0008-5472.can-15-1456 · Cited by 325 · see citing works

IDO Is a Nodal Pathogenic Driver of Lung Cancer and Metastasis Development

Smith, C., Chang, M. Y., Parker, K. H., Beury, D. W., DuHadaway, J. B., Flick, H. E., Boulden, J., Sutanto‐Ward, E., Soler, A. P., Laury‐Kleintop, L. D., et al. (2012) · Cancer Discovery · doi:10.1158/2159-8290.cd-12-0014 · Cited by 320 · see citing works

Reverse signaling through GITR ligand enables dexamethasone to activate IDO in allergy

Grohmann, U., Volpi, C., Fallarino, F., Bozza, S., Bianchi, R., Vacca, C., Orabona, C., Belladonna, M. L., Ayroldi, E., Nocentini, G., et al. (2007) · Nature Medicine · doi:10.1038/nm1563 · Cited by 316 · see citing works

First-in-human phase I study of the oral inhibitor of indoleamine 2,3-dioxygenase-1 epacadostat (INCB024360) in patients with advanced solid malignancies

Beatty, G. L., O'Dwyer, P. J., Clark, J., Shi, J. G., Bowman, K. J., Scherle, P. A., Newton, R. C., Schaub, R., Maleski, J., Leopold, L., et al. (2017) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-16-2272 · Cited by 314 · see citing works

The kynurenine pathway and neurodegenerative disease

Maddison, D. C., & Giorgini, F. (2015) · Seminars in Cell & Developmental Biology · doi:10.1016/j.semcdb.2015.03.002 · Cited by 309 · see citing works

Indolamine 2,3‐dioxygenase is expressed in the CNS and down‐regulates autoimmune inflammation

Kwidzinski, E., Bunse, J., Aktas, O., Richter, D., Mutlu, L., Zipp, F., Nitsch, R., & Bechmann, I. (2005) · The FASEB Journal · doi:10.1096/fj.04-3228fje · Cited by 304 · see citing works

Nanoparticle-mediated codelivery of myelin antigen and a tolerogenic small molecule suppresses experimental autoimmune encephalomyelitis

Yeste, A., Nadeau, M., Burns, E. J., Weiner, H. L., & Quintana, F. J. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1120611109 · Cited by 303 · see citing works

Toll-Like Receptor Engagement Enhances the Immunosuppressive Properties of Human Bone Marrow-Derived Mesenchymal Stem Cells by Inducing Indoleamine-2,3-dioxygenase-1 via Interferon-β and Protein Kinase R

Opitz, C. A., Litzenburger, U. M., Lutz, C., Lanz, T. V., Tritschler, I., Köppel, A., Tolosa, E., Hoberg, M., Anderl, J., Aicher, W. K., et al. (2009) · Stem Cells · doi:10.1002/stem.7 · Cited by 299 · see citing works

1-Methyl-DL-tryptophan, beta-(3-benzofuranyl)-DL-alanine (the oxygen analog of tryptophan), and beta-[3-benzo(b)thienyl]-DL-alanine (the sulfur analog of tryptophan) are competitive inhibitors for indoleamine 2,3-dioxygenase.

Cady, S. G., & Sono, M. (1991) · Archives of Biochemistry and Biophysics · doi:10.1016/0003-9861(91)90142-6 · Cited by 298 · see citing works

A TDO2-AhR Signaling Axis Facilitates Anoikis Resistance and Metastasis in Triple-Negative Breast Cancer

D'Amato, N. C., Rogers, T. J., Gordon, M. A., Greene, L. I., Cochrane, D. R., Spoelstra, N. S., Nemkov, T. G., D'Alessandro, A., Hansen, K. C., & Richer, J. K. (2015) · Cancer Research · doi:10.1158/0008-5472.can-15-2011 · Cited by 294 · see citing works

Induction of pulmonary indoleamine 2,3-dioxygenase by interferon.

Yoshida, R., Imanishi, J., Oku, T., Kishida, T., & Hayaishi, O. (1981) · Proceedings of the National Academy of Sciences of the United States of America · doi:10.1073/pnas.78.1.129 · Cited by 288 · see citing works

Indoleamine 2,3-Dioxygenase and Its Therapeutic Inhibition in Cancer

Prendergast, G. C., Malachowski, W. P., Mondal, A., Scherle, P., & Muller, A. J. (2017) · International review of cytology · doi:10.1016/bs.ircmb.2017.07.004 · Cited by 274 · see citing works

Tryptophan 2,3-dioxygenase is a key modulator of physiological neurogenesis and anxiety-related behavior in mice

Kanai, M., Funakoshi, H., Takahashi, H., Hayakawa, T., Mizuno, S., Matsumoto, K., & Nakamura, T. (2009) · Molecular Brain · doi:10.1186/1756-6606-2-8 · Cited by 273 · see citing works

Indoleamine 2,3-dioxygenase–expressing mature human monocyte-derived dendritic cells expand potent autologous regulatory T cells

Chung, D. J., Rossi, M., Romano, E., Ghith, J., Yuan, J. D., Munn, D. H., & Young, J. W. (2009) · Blood · doi:10.1182/blood-2008-11-191197 · Cited by 264 · see citing works

Increased serum kynurenine/tryptophan ratio correlates with disease progression in lung cancer

Suzuki, Y., Suda, T., Furuhashi, K., Suzuki, M., Fujie, M., Hahimoto, D., Nakamura, Y., Inui, N., Nakamura, H., & Chida, K. (2009) · Lung Cancer · doi:10.1016/j.lungcan.2009.05.001 · Cited by 263 · see citing works

The Kynurenine Pathway Modulates Neurodegeneration in a Drosophila Model of Huntington's Disease

Campesan, S., Green, E. W., Breda, C., Sathyasaikumar, K. V., Muchowski, P. J., Schwarcz, R. M., Kyriacou, C. P., & Giorgini, F. (2011) · Current Biology · doi:10.1016/j.cub.2011.04.028 · Cited by 261 · see citing works

Impaired Kynurenine Pathway Metabolism in The Prefrontal Cortex of Individuals With Schizophrenia

Sathyasaikumar, K. V., Stachowski, E. K., Wonodi, I., Roberts, R. C., Rassoulpour, A., McMahon, R. P., & Schwarcz, R. M. (2010) · Schizophrenia Bulletin · doi:10.1093/schbul/sbq112 · Cited by 253 · see citing works

Protein and amino acid restriction, aging and disease: from yeast to humans

Mirzaei, H., Suarez, J. A., & Longo, V. D. (2014) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2014.07.002 · Cited by 248 · see citing works

Role of the Kynurenine Metabolism Pathway in Inflammation-Induced Depression: Preclinical Approaches

Dantzer, R. (2016) · Current topics in behavioral neurosciences · doi:10.1007/7854_2016_6 · Cited by 248 · see citing works

NAD Deficiency, Congenital Malformations, and Niacin Supplementation

Shi, H., Enriquez, A., Rapadas, M., Martin, E. M. M. A., Wang, R., Moreau, J., Lim, C. K., Szot, J. O., Ip, E., Hughes, J. N., et al. (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1616361 · Cited by 246 · see citing works

Serum tryptophan decrease correlates with immune activation and impaired quality of life in colorectal cancer

Huang, A., Fuchs, D., Widner, B., Glover, C., Henderson, D. C., & Allen-Mersh, T. G. (2002) · British Journal of Cancer · doi:10.1038/sj.bjc.6600336 · Cited by 241 · see citing works

Inverse Correlation between Tumoral Indoleamine 2,3-Dioxygenase Expression and Tumor-Infiltrating Lymphocytes in Endometrial Cancer: Its Association with Disease Progression and Survival

Ino, K., Yamamoto, E., Shibata, K., Kajiyama, H., Yoshida, N., Terauchi, M., Nawa, A., Nagasaka, T., Takikawa, O., & Kikkawa, F. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-4144 · Cited by 241 · see citing works

Role of indoleamine 2,3-dioxygenase in health and disease

Yeung, A. W. S., Terentis, A. C., King, N. J. C., & Thomas, S. R. (2015) · Clinical Science · doi:10.1042/cs20140392 · Cited by 235 · see citing works

Effect of indoleamine 2,3-dioxygenase on induction of experimental autoimmune encephalomyelitis

Sakurai, K., Zou, J.-P., Tschetter, J. R., Ward, J. M., & Shearer, G. M. (2002) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(02)00176-5 · Cited by 227 · see citing works

Kynurenine pathway metabolomics predicts and provides mechanistic insight into multiple sclerosis progression

Lim, C. K., Bilgin, A. A., Lovejoy, D., Tan, V., Bustamante, S., Taylor, B., Bessède, A., Brew, B., & Guillemin, G. (2017) · Scientific Reports · doi:10.1038/srep41473 · Cited by 224 · see citing works

Therapeutic potential of human umbilical cord mesenchymal stem cells in the treatment of rheumatoid arthritis

Liu, Y., Mu, R., Wang, S., Li, L., Liu, X., Li, R., Sun, J., Guo, J., Zhang, X., Guo, J., et al. (2010) · Arthritis Research & Therapy · doi:10.1186/ar3187 · Cited by 220 · see citing works

Indoleamine 2,3-Dioxygenase and Tolerance: Where Are We Now?

Mellor, A. L., Lemos, H. D. P., & Huang, L. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.01360 · Cited by 220 · see citing works

Mechanisms of amino acid-mediated lifespan extension in Caenorhabditis elegans

Edwards, C., Canfield, J., Copes, N., Brito, A. G., Rehan, M. A. Y., Lipps, D., Brunquell, J., Westerheide, S. D., & Bradshaw, P. C. (2015) · BMC Genetics · doi:10.1186/s12863-015-0167-2 · Cited by 218 · see citing works

Role of the immunosuppressive enzyme indoleamine 2,3-dioxygenase in the progression of ovarian carcinoma

Inaba, T., Ino, K., Kajiyama, H., Yamamoto, E., Shibata, K., Nawa, A., Nagasaka, T., Akimoto, H., Takikawa, O., & Kikkawa, F. (2009) · Gynecologic Oncology · doi:10.1016/j.ygyno.2009.07.015 · Cited by 217 · see citing works

Role of tryptophan degradation in respiratory burst-independent antimicrobial activity of gamma interferon-stimulated human macrophages

Murray, H. W., Szuro-Sudol, A., Wellner, D., Oca, M. J., Granger, A. M., Libby, D., Rothermel, C. D., & Rubin, B. Y. (1989) · Infection and Immunity · doi:10.1128/iai.57.3.845-849.1989 · Cited by 216 · see citing works

Immune-modulating enzyme indoleamine 2,3-dioxygenase is effectively inhibited by targeting its apo-form

Nelp, M. T., Kates, P. A., Hunt, J. T., Newitt, J. A., Balog, A., Maley, D., Zhu, X. B., Abell, L. M., Allentoff, A. J., Borzilleri, R. M., et al. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1719190115 · Cited by 214 · see citing works

Synthesis and Biochemical Evaluation ofN-(4-Phenylthiazol-2-yl)benzenesulfonamides as High-Affinity Inhibitors of Kynurenine 3-Hydroxylase

Röver, S., Cesura, A. M., Huguenin, P. N., Kettler, R., & Szente, A. (1997) · Journal of Medicinal Chemistry · doi:10.1021/jm970467t · Cited by 212 · see citing works

Expression of Tryptophan 2,3-Dioxygenase and Production of Kynurenine Pathway Metabolites in Triple Transgenic Mice and Human Alzheimer's Disease Brain

Wu, W., Nicolazzo, J. A., Wen, L., Chung, R. S., Stankovic, R. K., Bao, S., Lim, C. K., Brew, B. J., Cullen, K. M., & Guillemin, G. J. (2013) · PLoS ONE · doi:10.1371/journal.pone.0059749 · Cited by 208 · see citing works

Inhibition of De Novo NAD + Synthesis by Oncogenic URI Causes Liver Tumorigenesis through DNA Damage

Tummala, K. S., Gomes, A. L., Yilmaz, M., Graña‐Castro, O., Bakiri, L., Ruppen, I., Ximénez‐Embún, P., Sheshappanavar, V., Rodriguez‐Justo, M., Pisano, D. G., et al. (2014) · Cancer Cell · doi:10.1016/j.ccell.2014.10.002 · Cited by 207 · see citing works

Reduction of kynurenic acid to quinolinic acid ratio in both the depressed and remitted phases of major depressive disorder

Savitz, J. B., Drevets, W. C., Wurfel, B. E., Ford, B. N., Bellgowan, P. S. F., Victor, T. A., Bodurka, J., Teague, T. K., & Dantzer, R. (2015) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2015.02.007 · Cited by 207 · see citing works

Challenges in the Discovery of Indoleamine 2,3-Dioxygenase 1 (IDO1) Inhibitors

Röhrig, U. F., Majjigapu, S. R., Vogel, P., Zoete, V., & Michielin, O. A. (2015) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.5b00326 · Cited by 206 · see citing works

SOCS3 drives proteasomal degradation of indoleamine 2,3-dioxygenase (IDO) and antagonizes IDO-dependent tolerogenesis

Orabona, C., Pallotta, M. T., Volpi, C., Fallarino, F., Vacca, C., Bianchi, R., Belladonna, M. L., Fioretti, M. C., Grohmann, U., & Puccetti, P. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0810278105 · Cited by 205 · see citing works

Immunity and Tolerance to Aspergillus Involve Functionally Distinct Regulatory T Cells and Tryptophan Catabolism

Montagnoli, C., Fallarino, F., Gaziano, R., Bozza, S., Bellocchio, S., Zelante, T., Kurup, W. P., Pitzurra, L., Puccetti, P., & Romani, L. R. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.176.3.1712 · Cited by 203 · see citing works

Tolerance to apoptotic cells is regulated by indoleamine 2,3-dioxygenase

Ravishankar, B., Liu, H., Shinde, R. S., Chandler, P., Baban, B., Tanaka, M., Munn, D. H., Mellor, A. L., Karlsson, M. C. I., & McGaha, T. L. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1117736109 · Cited by 199 · see citing works

Dioxin and immune regulation

Marshall, N. B., & Kerkvliet, N. I. (2010) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2009.05125.x · Cited by 197 · see citing works

Decreased Serum Tryptophan Concentration Predicts Poor Prognosis in Malignant Melanoma Patients

Weinlich, G., Murr, C., Richardsen, L., Winkler, C., & Fuchs, D. (2006) · Dermatology · doi:10.1159/000096906 · Cited by 197 · see citing works

Amino acid catabolism: a pivotal regulator of innate and adaptive immunity

McGaha, T. L., Huang, L., Lemos, H. D. P., Metz, R. A., Mautino, M. R., Prendergast, G. C., & Mellor, A. L. (2012) · Immunological Reviews · doi:10.1111/j.1600-065x.2012.01149.x · Cited by 197 · see citing works

An enzyme in the kynurenine pathway that governs vulnerability to suicidal behavior by regulating excitotoxicity and neuroinflammation

Brundin, L., Sellgren, C. M., Lim, C. K., Grit, J., Pålsson, E., Landén, M., Samuelsson, M., Lundgren, K., Brundin, P., Fuchs, D., et al. (2016) · Translational Psychiatry · doi:10.1038/tp.2016.133 · Cited by 195 · see citing works

Delaying aging and the aging-associated decline in protein homeostasis by inhibition of tryptophan degradation

van der Goot, A. T., Zhu, W., Vázquez‐Manrique, R. P., Seinstra, R. I., Dettmer, K., Michels, H., Farina, F., Krijnen, J., Melki, R., Buijsman, R. C., et al. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1203083109 · Cited by 192 · see citing works

IDO2 is critical for IDO1-mediated T-cell regulation and exerts a non-redundant function in inflammation

Metz, R. A., Smith, C., DuHadaway, J. B., Chandler, P., Baban, B., Merlo, L. M. F., Pigott, E., Keough, M. P., Rust, S., Mellor, A. L., et al. (2014) · International Immunology · doi:10.1093/intimm/dxt073 · Cited by 191 · see citing works

The cross talk between microbiota and the immune system: metabolites take center stage

Shapiro, H., Thaiss, C. A., Levy, M., & Elinav, E. (2014) · Current Opinion in Immunology · doi:10.1016/j.coi.2014.07.003 · Cited by 189 · see citing works

Reduction of Brain Kynurenic Acid Improves Cognitive Function

Kozak, R., Campbell, B. M., Strick, C. A., Horner, W., Hoffmann, W. E., Kiss, T., Chapin, D. S., McGinnis, D. J., Abbott, A. L., Roberts, B. M., et al. (2014) · Journal of Neuroscience · doi:10.1523/jneurosci.1107-14.2014 · Cited by 182 · see citing works

Tolerogenic dendritic cells

Takenaka, M. C., & Quintana, F. J. (2016) · Seminars in Immunopathology · doi:10.1007/s00281-016-0587-8 · Cited by 181 · see citing works

Role of IFN-gamma-induced indoleamine 2,3 dioxygenase and inducible nitric oxide synthase in the replication of human cytomegalovirus in retinal pigment epithelial cells.

Bodaghi, B., Goureau, O., Zipeto, D., Laurent, L., Virelizier, J. L., & Michelson, S. (1999) · PubMed · Cited by 180 · see citing works

Increasing production of homocysteine and neopterin and degradation of tryptophan with older age

Frick, B., Schroecksnadel, K., Neurauter, G., Leblhuber, F., & Fuchs, D. (2004) · Clinical Biochemistry · doi:10.1016/j.clinbiochem.2004.02.007 · Cited by 180 · see citing works

The Endogenous Tryptophan Metabolite and NAD+ Precursor Quinolinic Acid Confers Resistance of Gliomas to Oxidative Stress

Sahm, F., Oezen, I., Opitz, C. A., Radlwimmer, B., von Deimling, A., Ahrendt, T., Adams, S., Bode, H. B., Guillemin, G. J., Wick, W., et al. (2013) · Cancer Research · doi:10.1158/0008-5472.can-12-3831 · Cited by 176 · see citing works

Tryptophan Deprivation Induces Inhibitory Receptors ILT3 and ILT4 on Dendritic Cells Favoring the Induction of Human CD4+CD25+ Foxp3+ T Regulatory Cells

Brenk, M., Scheler, M., Koch, S., Neumann, J., Takikawa, O., Häcker, G. A., Bieber, T. R. M., & von Bubnoff, D. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0803277 · Cited by 176 · see citing works

A first in man phase I trial of the oral immunomodulator, indoximod, combined with docetaxel in patients with metastatic solid tumors

Soliman, H. H., Jackson, E., Neuger, T., Dees, E. C., Harvey, R. D., Han, H., Ismail-Khan, R., Minton, S., Vahanian, N. N., Link, C., et al. (2014) · Oncotarget · doi:10.18632/oncotarget.2357 · Cited by 174 · see citing works

New Insights into IDO Biology in Bacterial and Viral Infections

Schmidt, S. V., & Schultze, J. L. (2014) · Frontiers in Immunology · doi:10.3389/fimmu.2014.00384 · Cited by 172 · see citing works

Structural Insights into Substrate and Inhibitor Binding Sites in Human Indoleamine 2,3-Dioxygenase 1

Lewis-Ballester, A., Pham, K., Batabyal, D., Karkashon, S., Bonanno, J. B., Poulos, T. L., & Yeh, S. (2017) · Nature Communications · doi:10.1038/s41467-017-01725-8 · Cited by 171 · see citing works

Expression and prognosis role of indoleamine 2,3-dioxygenase in hepatocellular carcinoma

Pan, K., Wang, H., Chen, M.-S., Zhang, H.-K., Weng, D., Zhou, J., Huang, W. C., Li, X. H., Song, H.-F., & Xia, J. (2008) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-008-0395-1 · Cited by 169 · see citing works

An Aryl Hydrocarbon Receptor-Mediated Amplification Loop That Enforces Cell Migration in ER−/PR−/Her2− Human Breast Cancer Cells

Novikov, O., Wang, Z., Stanford, E. A., Parks, A. J., Ramirez-Cardenas, A., Landesman, E., Laklouk, I., Sarita-Reyes, C., Gusenleitner, D., Li, A., et al. (2016) · Molecular Pharmacology · doi:10.1124/mol.116.105361 · Cited by 167 · see citing works

Expression of indoleamine 2, 3‐dioxygenase and the recruitment of Foxp3‐expressing regulatory T cells in the development and progression of uterine cervical cancer

Nakamura, T., Shima, T., Saeki, A., 日高, 隆., Nakashima, A., Takikawa, O., & Saito, S. (2007) · Cancer Science · doi:10.1111/j.1349-7006.2007.00470.x · Cited by 166 · see citing works

Tryptophan metabolism: entering the field of aging and age-related pathologies

van der Goot, A. T., & Nollen, E. A. A. (2013) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2013.02.007 · Cited by 163 · see citing works

Phase Ia study of the indoleamine 2,3-dioxygenase 1 (IDO1) inhibitor navoximod (GDC-0919) in patients with recurrent advanced solid tumors

Nayak-Kapoor, A., Hao, Z., Sadek, R., Dobbins, R., Marshall, L., Vahanian, N. N., Ramsey, W. J., Kennedy, E. P., Mautino, M. R., Link, C. J., et al. (2018) · Journal for ImmunoTherapy of Cancer · doi:10.1186/s40425-018-0351-9 · Cited by 163 · see citing works

Kynurenine-3-monooxygenase inhibition prevents multiple organ failure in rodent models of acute pancreatitis

Mole, D. J., Webster, S. P., Uings, I., Zheng, X., Binnie, M., Wilson, K., Hutchinson, J. P., Mirguet, O., Walker, A. L., Beaufils, B., et al. (2016) · Nature Medicine · doi:10.1038/nm.4020 · Cited by 160 · see citing works

Lung cancer-derived galectin-1 contributes to cancer associated fibroblast-mediated cancer progression and immune suppression through TDO2/kynurenine axis

Hsu, Y.-L., Hung, J., Chiang, S.-Y., Jian, S., Wu, C.-Y., Lin, Y.-S., Tsai, Y., Chou, S., Tsai, M., & Kuo, P.-L. (2016) · Oncotarget · doi:10.18632/oncotarget.8488 · Cited by 158 · see citing works

Trace derivatives of kynurenine potently activate the aryl hydrocarbon receptor (AHR)

Seok, S.-H., Ma, Z.-X., Feltenberger, J. B., Chen, H., Chen, H., Scarlett, C., Lin, Z., Satyshur, K. A., Cortopassi, M., Jefcoate, C. R., et al. (2018) · Journal of Biological Chemistry · doi:10.1074/jbc.ra117.000631 · Cited by 157 · see citing works

Serum Metabolome and Lipidome Changes in Adult Patients with Primary Dengue Infection

Cui, L., Lee, Y. H., Kumar, Y., Xu, F., Lü, K., Ooi, E. E., Tannenbaum, S. R., & Ong, C. N. (2013) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0002373 · Cited by 155 · see citing works

Role of IFN-γ-Induced Indoleamine 2,3 Dioxygenase and Inducible Nitric Oxide Synthase in the Replication of Human Cytomegalovirus in Retinal Pigment Epithelial Cells

Bodaghi, B., Goureau, O., Zipeto, D., Laurent, L., Virelizier, J., & Michelson, S. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.162.2.957 · Cited by 154 · see citing works

Tryptophan-2,3-dioxygenase (TDO) inhibition ameliorates neurodegeneration by modulation of kynurenine pathway metabolites

Breda, C., Sathyasaikumar, K. V., Sograte‐Idrissi, S., Notarangelo, F. M., Estranero, J. G., Moore, G. G. L., Green, E. W., Kyriacou, C. P., Schwarcz, R. M., & Giorgini, F. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1604453113 · Cited by 153 · see citing works

Expression of Indoleamine 2,3-Dioxygenase in Metastatic Pancreatic Ductal Adenocarcinoma Recruits Regulatory T Cells to Avoid Immune Detection

Witkiewicz, A., Williams, T. K., Cozzitorto, J. A., Durkan, B., Showalter, S. L., Yeo, C. J., & Brody, J. R. (2008) · Journal of the American College of Surgeons · doi:10.1016/j.jamcollsurg.2007.12.014 · Cited by 150 · see citing works

PD-1/PD-L1 blockade enhances T-cell activity and antitumor efficacy of imatinib in gastrointestinal stromal tumors

Seifert, A. M., Zeng, S., Zhang, J. Q., Kim, T. S., Cohen, N. A., Beckman, M. J., Medina, B. D., Maltbaek, J. H., Loo, J. K., Crawley, M. H., et al. (2017) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-16-1163 · Cited by 149 · see citing works

Efficacy of Levo-1-Methyl Tryptophan and Dextro-1-Methyl Tryptophan in Reversing Indoleamine-2,3-Dioxygenase–Mediated Arrest of T-Cell Proliferation in Human Epithelial Ovarian Cancer

Qian, F., Villella, J., Wallace, P. K., Mhawech-Fauceglia, P. Y., Tario, J. D., Andrews, C., Matsuzaki, J., Valmori, D., Ayyoub, M., Frederick, P. J., et al. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-2106 · Cited by 147 · see citing works

Dietary Protein, Metabolism, and Aging

Soultoukis, G. A., & Partridge, L. (2016) · Annual Review of Biochemistry · doi:10.1146/annurev-biochem-060815-014422 · Cited by 147 · see citing works

A phase I study of indoximod in patients with advanced malignancies

Soliman, H. H., Minton, S. E., Han, H. S., Ismail-Khan, R. R., Neuger, A. M., Khambati, F. A., Noyes, D. R., Lush, R. M., Chiappori, A., Roberts, J. D., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.8216 · Cited by 145 · see citing works

Interferon‐lnduced Indoleamine 2,3‐Dioxygenase Activity in Human Mononuclear Phagocytes

Carlin, J. M., Borden, E. C., Sondel, P., & Byrne, G. I. (1989) · Journal of Leukocyte Biology · doi:10.1002/jlb.45.1.29 · Cited by 144 · see citing works

The indoleamine 2,3-dioxygenase pathway controls complement-dependent enhancement of chemo-radiation therapy against murine glioblastoma

Li, M., Bolduc, A. R., Hoda, M. N., Gamble, D. N., Dolisca, S.-B., Bolduc, A., Hoang, K., Ashley, C., McCall, D. C., Rojiani, A. M., et al. (2014) · Journal for ImmunoTherapy of Cancer · doi:10.1186/2051-1426-2-21 · Cited by 144 · see citing works

Tolerogenic Phenotype of IFN-γ–Induced IDO+ Dendritic Cells Is Maintained via an Autocrine IDO–Kynurenine/AhR–IDO Loop

Li, Q., Harden, J. L., Anderson, C. D., & Egilmez, N. K. (2016) · The Journal of Immunology · doi:10.4049/jimmunol.1502615 · Cited by 144 · see citing works

Discovery of a Novel and Selective Indoleamine 2,3-Dioxygenase (IDO-1) Inhibitor 3-(5-Fluoro-1 H -indol-3-yl)pyrrolidine-2,5-dione (EOS200271/PF-06840003) and Its Characterization as a Potential Clinical Candidate

Crosignani, S., Bingham, P., Bottemanne, P., Cannelle, H., Cauwenberghs, S., Cordonnier, M., Dalvie, D., Deroose, F. D., Feng, J. L., Gomes, B., et al. (2017) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.7b00974 · Cited by 144 · see citing works

The Indoleamine-2,3-Dioxygenase (IDO) Inhibitor 1-Methyl-D-tryptophan Upregulates IDO1 in Human Cancer Cells

Opitz, C. A., Litzenburger, U. M., Opitz, U., Sahm, F., Ochs, K., Lutz, C., Wick, W., & Platten, M. (2011) · PLoS ONE · doi:10.1371/journal.pone.0019823 · Cited by 143 · see citing works

Laquinimod arrests experimental autoimmune encephalomyelitis by activating the aryl hydrocarbon receptor

Kaye, J., Piryatinsky, V., Birnberg, T., Hingaly, T., Raymond, E., Kashi, R., Amit‐Romach, E., Caballero, I. S., Towfic, F., Ator, M. A., et al. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1607843113 · Cited by 141 · see citing works

Important Hydrogen Bond Networks in Indoleamine 2,3-Dioxygenase 1 (IDO1) Inhibitor Design Revealed by Crystal Structures of Imidazoleisoindole Derivatives with IDO1

Peng, Y., Ueng, S., Tseng, C., Hung, M., Song, J., Wu, J., Liao, F.-Y., Fan, Y.-S., Wu, M.-H., Hsiao, W., et al. (2015) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.5b01390 · Cited by 139 · see citing works

Indoleamine 2,3-dioxygenase activity in nonagenarians is markedly increased and predicts mortality

Pertovaara, M., Raitala, A., Lehtimäki, T. J., Karhunen, P. J., Oja, S. S., Jylhä, M. K., Hervonen, A., & Hurme, M. (2006) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2006.01.020 · Cited by 136 · see citing works

Mouse chronic social stress increases blood and brain kynurenine pathway activity and fear behaviour: Both effects are reversed by inhibition of indoleamine 2,3-dioxygenase

Fuertig, R., Azzinnari, D., Bergamini, G., Cathomas, F., Sigrist, H., Seifritz, E., Vavassori, S., Luippold, A., Hengerer, B., Ceci, A., et al. (2016) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2015.12.020 · Cited by 135 · see citing works

Inflammation-induced depression: Its pathophysiology and therapeutic implications

Jeon, S. W., & Kim, Y.-K. (2017) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2017.10.016 · Cited by 134 · see citing works

Combined KIT and CTLA-4 Blockade in Patients with Refractory GIST and Other Advanced Sarcomas: A Phase Ib Study of Dasatinib plus Ipilimumab

D’Angelo, S. P., Shoushtari, A. N., Keohan, M. L., Dickson, M. A., Gounder, M. M., Chi, P., Loo, J. K., Gaffney, L., Schneider, L., Patel, Z. M., et al. (2016) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-16-2349 · Cited by 133 · see citing works

Identification of Cinnabarinic Acid as a Novel Endogenous Aryl Hydrocarbon Receptor Ligand That Drives IL-22 Production

Lowe, M. M., Mold, J. E., Kanwar, B., Huang, Y., Louie, A., Pollastri, M. P., Wang, C., Patel, G., Franks, D. G., Schlezinger, J. J., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0087877 · Cited by 129 · see citing works

Indoleamine 2,3 dioxygenase–mediated tryptophan catabolism regulates accumulation of Th1/Th17 cells in the joint in collagen‐induced arthritis

Criado, G., Šimelyte, E., Inglis, J. J., Essex, D. W., & Williams, R. O. (2009) · Arthritis & Rheumatism · doi:10.1002/art.24446 · Cited by 127 · see citing works

High doses of CpG oligodeoxynucleotides stimulate a tolerogenic TLR9–TRIF pathway

Volpi, C., Fallarino, F., Pallotta, M. T., Bianchi, R., Vacca, C., Belladonna, M. L., Orabona, C., LUCA, A. D., Boon, L., Romani, L. R., et al. (2013) · Nature Communications · doi:10.1038/ncomms2874 · Cited by 126 · see citing works

Association of amine biomarkers with incident dementia and Alzheimer's disease in the Framingham Study

Chouraki, V. A., Preis, S. R., Yang, Q., Beiser, A., Li, S., Larson, M. G., Weinstein, G., Wang, T. J., Gerszten, R. E., Vasan, R. S., et al. (2017) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2017.04.009 · Cited by 122 · see citing works

Nanosensor Detection of an Immunoregulatory Tryptophan Influx/Kynurenine Efflux Cycle

Kaper, T., Looger, L. L., Takanaga, H., Platten, M., Steinman, L., & Frommer, W. B. (2007) · PLoS Biology · doi:10.1371/journal.pbio.0050257 · Cited by 121 · see citing works

The effects of a novel and selective inhibitor of tryptophan 2,3-dioxygenase on tryptophan and serotonin metabolism in the rat

Salter, M., Hazelwood, R., Pogson, C. I., Iyer, R., & Madge, D. J. (1995) · Biochemical Pharmacology · doi:10.1016/0006-2952(95)00006-l · Cited by 119 · see citing works

The Immunoregulatory Enzyme IDO Paradoxically Drives B Cell-Mediated Autoimmunity

Scott, G. N., DuHadaway, J., Pigott, E., Ridge, N., Prendergast, G., Muller, A., & Mandik-Nayak, L. (2009) · Journal of Immunology · doi:10.4049/jimmunol.0804328 · Cited by 114 · see citing works

Indoleamine 2,3-dioxygenase in infection: the paradox of an evasive strategy that benefits the host

Zelante, T., Fallarino, F., Bistoni, F., Puccetti, P., & Romani, L. R. (2008) · Microbes and Infection · doi:10.1016/j.micinf.2008.10.007 · Cited by 114 · see citing works

The IDO–AhR Axis Controls Th17/Treg Immunity in a Pulmonary Model of Fungal Infection

de Araújo, E. F., Feriotti, C., Galdino, N. A. D. L., Preite, N. W., Calich, V. L. G., & Loures, F. V. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.00880 · Cited by 111 · see citing works

IDO2 is a critical mediator of autoantibody production and inflammatory pathogenesis in a mouse model of autoimmune arthritis

Merlo, L. M. F., Pigott, E., DuHadaway, J., Grabler, S., Metz, R., Prendergast, G., & Mandik-Nayak, L. (2014) · Journal of Immunology · doi:10.4049/jimmunol.1303012 · Cited by 110 · see citing works

Indoleamine 2,3-dioxygenase-1 is protective in atherosclerosis and its metabolites provide new opportunities for drug development

Cole, J. E., Astola, N., Cribbs, A. P., Goddard, M. E., Park, I., Green, P. A., Davies, A. H., Williams, R. O., Feldmann, M., & Monaco, C. G. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1517820112 · Cited by 108 · see citing works

The KMO allele encoding Arg452 is associated with psychotic features in bipolar disorder type 1, and with increased CSF KYNA level and reduced KMO expression

Lavebratt, C., Olsson, S., Backlund, L., Frisén, L., Sellgren, C. M., Priebe, L., Nikamo, P., Träskman‐Bendz, L., Cichon, S., Vawter, M. P., et al. (2013) · Molecular Psychiatry · doi:10.1038/mp.2013.11 · Cited by 108 · see citing works

IDO-expressing regulatory dendritic cells in cancer and chronic infection

Popov, A., & Schultze, J. L. (2007) · Journal of Molecular Medicine · doi:10.1007/s00109-007-0262-6 · Cited by 108 · see citing works

Blocking Indolamine-2,3-Dioxygenase Rebound Immune Suppression Boosts Antitumor Effects of Radio-Immunotherapy in Murine Models and Spontaneous Canine Malignancies

Monjazeb, A. M., Kent, M. S., Grossenbacher, S. K., Minnar, C. M., Zamora, A. E., Mirsoian, A., Chen, M., Kol, A., Shiao, S. L., Reddy, A., et al. (2016) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-15-3026 · Cited by 108 · see citing works

Cyclooxygenase inhibition targets neurons to prevent early behavioural decline in Alzheimer’s disease model mice

Woodling, N. S., Colas, D., Wang, Q., Minhas, P. S., Panchal, M., Liang, X., Mhatre, S. D., Brown, H. D., Ko, N., Zagol-Ikapitte, I. A., et al. (2016) · Brain · doi:10.1093/brain/aww117 · Cited by 108 · see citing works

A genome-wide association study of kynurenic acid in cerebrospinal fluid: implications for psychosis and cognitive impairment in bipolar disorder

Sellgren, C. M., Kegel, M. E., Bergen, S. E., Ekman, C. J., Olsson, S., Larsson, M. K., Vawter, M. P., Backlund, L., Sullivan, P. F., Sklar, P. B., et al. (2015) · Molecular Psychiatry · doi:10.1038/mp.2015.186 · Cited by 106 · see citing works

IDO Mediates TLR9-Driven Protection from Experimental Autoimmune Diabetes

Fallarino, F., Volpi, C., Zelante, T., Vacca, C., Calvitti, M., Fioretti, M. C., Puccetti, P., Romani, L. R., & Grohmann, U. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0901577 · Cited by 105 · see citing works

Inhibition of human herpes simplex virus type 2 by interferon γ and tumor necrosis factor α is mediated by indoleamine 2,3-dioxygenase

Adams, O., Besken, K., Oberdörfer, C., MacKenzie, C. R., Rüßing, D., & Däubener, W. (2004) · Microbes and Infection · doi:10.1016/j.micinf.2004.04.007 · Cited by 105 · see citing works

A patent review of IDO1 inhibitors for cancer

Cheong, J. E., Ekkati, A. R., & Sun, L. (2018) · Expert Opinion on Therapeutic Patents · doi:10.1080/13543776.2018.1441290 · Cited by 104 · see citing works

A new, simple, bioassay for human IFN-γ

Däubener, W., Wanagat, N., Pilz, K., Seghrouchni, S., Fischer, H., & Hadding, U. (1994) · Journal of Immunological Methods · doi:10.1016/0022-1759(94)90207-0 · Cited by 100 · see citing works

Tryptophan degradation in autoimmune diseases

Opitz, C. A., Wick, W., Steinman, L., & Platten, M. (2007) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-007-7140-9 · Cited by 100 · see citing works

Reducing cannabinoid abuse and preventing relapse by enhancing endogenous brain levels of kynurenic acid

Justinová, Z., Mascia, P., Wu, H., Secci, M. E., Redhi, G. H., Panlilio, L. V., Scherma, M., Barnes, C., Parashos, A., Zara, T., et al. (2013) · Nature Neuroscience · doi:10.1038/nn.3540 · Cited by 99 · see citing works

Antimicrobial and immunoregulatory properties of human tryptophan 2,3‐dioxygenase

Schmidt, S., Müller, A., Heseler, K., Woite, C., Spekker, K., Mackenzie, C., & Däubener, W. (2009) · European Journal of Immunology · doi:10.1002/eji.200939535 · Cited by 97 · see citing works

Enhanced Longevity by Ibuprofen, Conserved in Multiple Species, Occurs in Yeast through Inhibition of Tryptophan Import

He, C. Z., Tsuchiyama, S. K., Nguyen, Q. T. T., Proshkina, E., Terrill, S. R., Sahibzada, S., Patel, B., Faulkner, A. R., Shaposhnikov, M. V., Tian, R., et al. (2014) · PLoS Genetics · doi:10.1371/journal.pgen.1004860 · Cited by 97 · see citing works

Activation of the kynurenine pathway and increased production of the excitotoxin quinolinic acid following traumatic brain injury in humans

Yan, E., Frugier, T., Lim, C. K., Heng, B., Sundaram, G., Tan, M., Rosenfeld, J. V., Walker, D. W., Guillemin, G., & Morganti-Kossmann, M. (2015) · Journal of Neuroinflammation · doi:10.1186/s12974-015-0328-2 · Cited by 96 · see citing works

Indoleamine 2,3 Dioxygenase (IDO) Expression and Activity in Relapsing- Remitting Multiple Sclerosis

Mancuso, R., Hernis, A., Agostini, S., Rovaris, M., Caputo, D., Fuchs, D., & Clerici, M. (2015) · PLoS ONE · doi:10.1371/journal.pone.0130715 · Cited by 93 · see citing works

The end of the road for the tryptophan depletion concept in pregnancy and infection

Badawy, A. A.-B., Namboodiri, A. M. A., & Moffett, J. R. (2016) · Clinical Science · doi:10.1042/cs20160153 · Cited by 92 · see citing works

Inhibition ofChlamydia pneumoniaeReplication in HEp‐2 Cells by Interferon‐g: Role of Tryptophan Catabolism

Mehta, S. J., Miller, R. D., Ramírez, J. A., & Summersgill, J. T. (1998) · The Journal of Infectious Diseases · doi:10.1086/515287 · Cited by 91 · see citing works

Elevated levels of kynurenic acid during gestation produce neurochemical, morphological, and cognitive deficits in adulthood: Implications for schizophrenia

Pershing, M. L., Bortz, D. M., Pocivavsek, A., Fredericks, P. J., Jørgensen, C. V., Vunck, S. A., Leuner, B., Schwarcz, R. M., & Bruno, J. P. (2014) · Neuropharmacology · doi:10.1016/j.neuropharm.2014.10.017 · Cited by 90 · see citing works

Discovery of Brain-Penetrant, Irreversible Kynurenine Aminotransferase II Inhibitors for Schizophrenia

Dounay, A. B., Anderson, M. D., Bechle, B. M., Campbell, B. M., Claffey, M. M., Evdokimov, A. G., Evrard, E., Fonseca, K. R., Gan, X., Ghosh, S., et al. (2012) · ACS Medicinal Chemistry Letters · doi:10.1021/ml200204m · Cited by 89 · see citing works

The IDO Inhibitor Coptisine Ameliorates Cognitive Impairment in a Mouse Model of Alzheimer's Disease

Yu, D., Tao, B.-B., Yang, Y.-Y., Du, L., Yang, S.-S., He, X.-J., Zhu, Y., Yan, J., & Yang, Q. (2014) · Journal of Alzheimer's Disease · doi:10.3233/jad-140414 · Cited by 88 · see citing works

Accumulation of an Endogenous Tryptophan-Derived Metabolite in Colorectal and Breast Cancers

Puccetti, P., Fallarino, F., Italiano, A., Soubeyran, I., MacGrogan, G. M., Debled, M., Velasco, V., Bodet, D., Eimer, S., Veldhoen, M., et al. (2015) · PLoS ONE · doi:10.1371/journal.pone.0122046 · Cited by 87 · see citing works

Effects of Kynurenine Pathway Inhibition on NAD+ Metabolism and Cell Viability in Human Primary Astrocytes and Neurons

Braidy, N., Guillemin, G., & Grant, R. (2011) · International Journal of Tryptophan Research · doi:10.4137/ijtr.s7052 · Cited by 87 · see citing works

Kynurenine-3-monooxygenase: a review of structure, mechanism, and inhibitors.

Smith, J. R., Jamie, J., & Guillemin, G. (2016) · Drug Discovery Today · doi:10.1016/j.drudis.2015.11.001 · Cited by 87 · see citing works

Abstract 491: NLG919, a novel indoleamine-2,3-dioxygenase (IDO)-pathway inhibitor drug candidate for cancer therapy.

Mautino, M. R., Jaipuri, F. A., Waldo, J. P., Kumar, S., Adams, J., Allen, C. V., Marcinowicz-Flick, A., Munn, D. H., Vahanian, N. N., & Link, C. J. (2013) · Cancer Research · doi:10.1158/1538-7445.am2013-491 · Cited by 86 · see citing works

Indoleamine 2,3-dioxygenase activity and clinical outcome following induction chemotherapy and concurrent chemoradiation in Stage III non-small cell lung cancer

Creelan, B., Antonia, S. J., Bepler, G., Garrett, T. J., Simon, G. R., & Soliman, H. H. (2013) · OncoImmunology · doi:10.4161/onci.23428 · Cited by 86 · see citing works

1-Methyl-Tryptophan Can Interfere with TLR Signaling in Dendritic Cells Independently of IDO Activity

Agaugué, S., Perrin‐Cocon, L., Coutant, F., André, P., & Lotteau, V. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.177.4.2061 · Cited by 86 · see citing works

Beta interferon inhibits Toxoplasma gondii growth in human monocyte-derived macrophages

Schmitz, J., Carlin, J. M., Borden, E. C., & Byrne, G. I. (1989) · Infection and Immunity · doi:10.1128/iai.57.10.3254-3256.1989 · Cited by 86 · see citing works

On watching the watchers: IDO and type I/II IFN

Puccetti, P. (2007) · European Journal of Immunology · doi:10.1002/eji.200737184 · Cited by 84 · see citing works

Association of a polymorphism in the indoleamine- 2,3-dioxygenase gene and interferon-α-induced depression in patients with chronic hepatitis C

Smith, A. K., Simon, J. S., Gustafson, E. L., Noviello, S., Cubells, J. F., Epstein, M. P., Devlin, D. J., Qiu, P., Albrecht, J. K., Brass, C. A., et al. (2012) · Molecular Psychiatry · doi:10.1038/mp.2011.67 · Cited by 84 · see citing works

Tryptophan degradation in patients with gynecological cancer correlates with immune activation

Schroecksnadel, K., Winkler, C., Fuith, L. C., & Fuchs, D. (2004) · Cancer Letters · doi:10.1016/j.canlet.2004.10.033 · Cited by 84 · see citing works

Chromatographic analysis of tryptophan metabolites

Sadok, I., Gamian, A., & Staniszewska, M. (2017) · Journal of Separation Science · doi:10.1002/jssc.201700184 · Cited by 84 · see citing works

Histology and survival in age-delayed low-tryptophan-fed rats

Ooka, H., Segall, P. E., & Timiras, P. S. (1988) · Mechanisms of Ageing and Development · doi:10.1016/0047-6374(88)90099-1 · Cited by 83 · see citing works

Cinnabarinic acid and xanthurenic acid: Two kynurenine metabolites that interact with metabotropic glutamate receptors

Fazio, F., Lionetto, L., Curto, M., Iacovelli, L., Copeland, C., Neale, S., Bruno, V., Battaglia, G., Salt, T., & Nicoletti, F. (2017) · Neuropharmacology · doi:10.1016/j.neuropharm.2016.06.020 · Cited by 83 · see citing works

Serum aminoterminal type III procollagen peptide reflects repair after acute myocardial infarction.

Jensen, L. T., Hørslev-Petersen, K., Toft, P. B., Bentsen, K. D., Grande, P., Simonsen, E. E., & Lorenzen, I. (1990) · Circulation · doi:10.1161/01.cir.81.1.52 · Cited by 82 · see citing works

Myeloid-derived suppressor cells in the era of increasing myeloid cell diversity

Veglia, F., Sanseviero, E., & Gabrilovich, D. I. (2021) · Nature Reviews Immunology · doi:10.1038/s41577-020-00490-y · Cited by 1,940 · see citing works

Microbiota–gut–brain axis and its therapeutic applications in neurodegenerative diseases

Loh, J. S., Mak, W. Q., Tan, L. K. S., Ng, C. X., Chan, H. H., Yeow, S. H., Foo, J. B., Ong, Y. S., How, C. W., & Khaw, K. Y. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01743-1 · Cited by 1,193 · see citing works

Glioblastoma in adults: a Society for Neuro-Oncology (SNO) and European Society of Neuro-Oncology (EANO) consensus review on current management and future directions

Wen, P. Y., Weller, M., Lee, E. Q., Alexander, B. M., Barnholtz-Sloan, J. S., Barthel, F. P., Batchelor, T. T., Bindra, R. S., Chang, S. M., Chiocca, E. A., et al. (2020) · Neuro-Oncology · doi:10.1093/neuonc/noaa106 · Cited by 1,168 · see citing works

Targeting Metabolism to Improve the Tumor Microenvironment for Cancer Immunotherapy

Bader, J. E., Voss, K., & Rathmell, J. C. (2020) · Molecular Cell · doi:10.1016/j.molcel.2020.05.034 · Cited by 1,038 · see citing works

T cells in health and disease

Sun, L., Su, Y., Jiao, A., Wang, X., & Zhang, B. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01471-y · Cited by 1,060 · see citing works

Myeloid-derived suppressor cells as immunosuppressive regulators and therapeutic targets in cancer

Li, K., Shi, H., Zhang, B., Ou, X., Ma, Q., Chen, Y., Shu, P., Li, D., & Wang, Y.-S. (2021) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-021-00670-9 · Cited by 914 · see citing works

Regulatory T cells in tumor microenvironment: new mechanisms, potential therapeutic strategies and future prospects

Li, C., Jiang, P., Wei, S., Xu, X., & Wang, J. (2020) · Molecular Cancer · doi:10.1186/s12943-020-01234-1 · Cited by 935 · see citing works

Small molecule metabolites: discovery of biomarkers and therapeutic targets

Qiu, S., Cai, Y., Yao, H., Lin, C., Xie, Y., Tang, S., & Zhang, A. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01399-3 · Cited by 939 · see citing works

Mechanisms and Implications of Metabolic Heterogeneity in Cancer

Kim, J., & DeBerardinis, R. J. (2019) · Cell Metabolism · doi:10.1016/j.cmet.2019.08.013 · Cited by 606 · see citing works

Cancer neuroscience: State of the field, emerging directions

Winkler, F., Venkatesh, H. S., Amit, M., Batchelor, T. T., Demir, İ. E., Deneen, B., Gutmann, D. H., Hervey‐Jumper, S. L., Kuner, T., Mabbott, D., et al. (2023) · Cell · doi:10.1016/j.cell.2023.02.002 · Cited by 578 · see citing works

IL4I1 Is a Metabolic Immune Checkpoint that Activates the AHR and Promotes Tumor Progression

Sadik, A., Patterson, L. F. S., Öztürk, S., Mohapatra, S. R., Panitz, V., Secker, P. F., Pfänder, P., Loth, S., Salem, H., Prentzell, M. T., et al. (2020) · Cell · doi:10.1016/j.cell.2020.07.038 · Cited by 563 · see citing works

Gut Microbiota-Derived Tryptophan Metabolites Maintain Gut and Systemic Homeostasis

Su, X., Gao, Y., & Yang, R. (2022) · Cells · doi:10.3390/cells11152296 · Cited by 424 · see citing works

Selective glutamine metabolism inhibition in tumor cells improves antitumor T lymphocyte activity in triple-negative breast cancer

Edwards, D. N., Ngwa, V. M., Raybuck, A. L., Wang, S., Hwang, Y., Kim, L. C., Cho, S. H., Paik, Y., Wang, Q., Zhang, S., et al. (2020) · Journal of Clinical Investigation · doi:10.1172/jci140100 · Cited by 379 · see citing works

Tryptophan Metabolism in Inflammaging: From Biomarker to Therapeutic Target

Sorgdrager, F. J. H., Naudé, P. J. W., Kema, I. P., Nollen, E. A. A., & Deyn, P. P. D. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.02565 · Cited by 372 · see citing works

Bifidobacterium breve CCFM1025 attenuates major depression disorder via regulating gut microbiome and tryptophan metabolism: A randomized clinical trial

Tian, P., Chen, Y., Zhu, H., Wang, L., Qian, X., Zou, R., Zhao, J., Zhang, H., Qian, L., Wang, Q., et al. (2021) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2021.11.023 · Cited by 365 · see citing works

Serotonin reduction in post-acute sequelae of viral infection

Wong, A. C., Devason, A. S., Umana, I. C., Cox, T. O., Dohnalová, L., Litichevskiy, L., Perla, J., Lundgren, P., Etwebi, Z., Izzo, L., et al. (2023) · Cell · doi:10.1016/j.cell.2023.09.013 · Cited by 359 · see citing works

Tryptophan Metabolism in Depression: A Narrative Review with a Focus on Serotonin and Kynurenine Pathways

Correia, A. S., & Vale, N. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23158493 · Cited by 356 · see citing works

Amino acid metabolism in immune cells: essential regulators of the effector functions, and promising opportunities to enhance cancer immunotherapy

Yang, L., Chu, Z., Liu, M., Zou, Q., Li, J., Liu, Q., Wang, Y., Wang, T., Xiang, J., & Wang, B. (2023) · Journal of Hematology & Oncology · doi:10.1186/s13045-023-01453-1 · Cited by 362 · see citing works

The impact of the microbiota-gut-brain axis on Alzheimer’s disease pathophysiology

Doifode, T., Giridharan, V. V., Generoso, J. S., Bhatti, G., Collodel, A., Schulz, P. E., Forlenza, O. V., & Barichello, T. (2021) · Pharmacological Research · doi:10.1016/j.phrs.2020.105314 · Cited by 347 · see citing works

Cancer cell metabolism and antitumour immunity

Martino, M. D., Rathmell, J. C., Galluzzi, L., & Vanpouille‐Box, C. (2024) · Nature reviews. Immunology · doi:10.1038/s41577-024-01026-4 · Cited by 363 · see citing works

Glioblastoma at the crossroads: current understanding and future therapeutic horizons

Singh, S., Dey, D., Barik, D., Mohapatra, I., Kim, S., Sharma, M., Prasad, S., Wang, P., Singh, A. R., & Singh, G. (2025) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-025-02299-4 · Cited by 332 · see citing works

Indoleamine 2,3-dioxygenase (IDO) inhibitors and cancer immunotherapy

Fujiwara, Y., Kato, S., Nesline, M., Conroy, J. M., DePietro, P., Pabla, S., & Kurzrock, R. (2022) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2022.102461 · Cited by 307 · see citing works

The therapeutic potential of targeting tryptophan catabolism in cancer

Opitz, C. A., Somarribas Patterson, L. F., Mohapatra, S. R., Dewi, D. L., Sadik, A., Platten, M., & Trump, S. (2020) · British Journal of Cancer · doi:10.1038/s41416-019-0664-6 · Cited by 300 · see citing works

Radiopharmaceuticals and their applications in medicine

Zhang, S., Wang, X., Gao, X., Chen, X., Li, L., Li, G., Liu, C., Miao, Y., Wang, R., & Hu, K. (2025) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-02041-6 · Cited by 317 · see citing works

Tryptophan in health and disease

Comai, S., Bertazzo, A., Brughera, M., & Crotti, S. (2020) · Advances in clinical chemistry · doi:10.1016/bs.acc.2019.08.005 · Cited by 300 · see citing works

The functional crosstalk between myeloid-derived suppressor cells and regulatory T cells within the immunosuppressive tumor microenvironment

Haist, M., Stege, H., Grabbe, S., & Bros, M. (2021) · Cancers · doi:10.3390/cancers13020210 · Cited by 295 · see citing works

Tryptophan Metabolism as a Pharmacological Target

Modoux, M., Rolhion, N., Mani, S., & Sokol, H. (2020) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2020.11.006 · Cited by 285 · see citing works

The relationship between nutrition and the immune system

Munteanu, C., & Schwartz, B. (2022) · Frontiers in Nutrition · doi:10.3389/fnut.2022.1082500 · Cited by 315 · see citing works

<i>Bifidobacterium longum</i> mediated tryptophan metabolism to improve atopic dermatitis via the gut-skin axis

Fang, Z., Pan, T., Li, L., Wang, H., Zhu, J., Zhang, H., Zhao, J., Chen, W., & Lu, W. (2022) · Gut Microbes · doi:10.1080/19490976.2022.2044723 · Cited by 273 · see citing works

Emerging therapies in cancer metabolism

Xiao, Y., Yu, T., Xu, Y., Ding, R., Wang, Y.-P., Jiang, Y., & Shao, Z. (2023) · Cell Metabolism · doi:10.1016/j.cmet.2023.07.006 · Cited by 266 · see citing works

Amino acid metabolism in tumor biology and therapy

Chen, J., Cui, L., Lu, S., & Xu, S. (2024) · Cell Death and Disease · doi:10.1038/s41419-024-06435-w · Cited by 268 · see citing works

Altered gut metabolites and microbiota interactions are implicated in colorectal carcinogenesis and can be non-invasive diagnostic biomarkers

Coker, O. O., Liu, C., Wu, W. K. K., Wong, S. H., Jia, W. P., Sung, J. J. �., & Yu, J. Q. (2022) · Microbiome · doi:10.1186/s40168-021-01208-5 · Cited by 258 · see citing works

MYC promotes tryptophan uptake and metabolism by the kynurenine pathway in colon cancerPreprint

Venkateswaran, N., Lafita‐Navarro, M. C., Hao, Y.-H., Kilgore, J. A., Perez‐Castro, L., Braverman, J., Borenstein‐Auerbach, N., Kim, M. G., Lesner, N. P., Mishra, P., et al. (2019) · Genes & Development · doi:10.1101/gad.327056.119 · Cited by 254 · see citing works

Intestinal microbiota-derived tryptophan metabolites are predictive of Ah receptor activity

Dong, F., Hao, F., Murray, I. A., Smith, P. B. W., Koo, I., Tindall, A. M., Kris‐Etherton, P. M., Gowda, K., Amin, S., Patterson, A. D., et al. (2020) · Gut Microbes · doi:10.1080/19490976.2020.1788899 · Cited by 252 · see citing works

Cellular metabolism regulates the differentiation and function of T-cell subsets

Ma, S., Ming, Y., Wu, J., & Cui, G. (2024) · Cellular and Molecular Immunology · doi:10.1038/s41423-024-01148-8 · Cited by 255 · see citing works

Indoleamine 2,3‐dioxygenase 1 (IDO1): an up‐to‐date overview of an eclectic immunoregulatory enzyme

Pallotta, M. T., Rossini, S., Suvieri, C., Coletti, A., Orabona, C., Macchiarulo, A., Volpi, C., & Grohmann, U. (2021) · FEBS Journal · doi:10.1111/febs.16086 · Cited by 243 · see citing works

Harnessing Nanomaterials for Cancer Sonodynamic Immunotherapy

Liang, S., Yao, J., Liu, D., Rao, L., Chen, X. S., & Wang, Z. (2023) · Advanced Materials · doi:10.1002/adma.202211130 · Cited by 245 · see citing works

Shining New Light on Biological Systems: Luminescent Transition Metal Complexes for Bioimaging and Biosensing Applications

Lee, L. C., & Lo, K. K. (2024) · Chemical Reviews · doi:10.1021/acs.chemrev.3c00629 · Cited by 248 · see citing works

Restoring hippocampal glucose metabolism rescues cognition across Alzheimer’s disease pathologies

Minhas, P. S., Jones, J. R., Latif‐Hernandez, A., Sugiura, Y., Durairaj, A. S., Wang, Q., Mhatre, S. D., Uenaka, T., Crapser, J. D., Conley, T. E., et al. (2024) · Science · doi:10.1126/science.abm6131 · Cited by 241 · see citing works

Butyrate ameliorates chronic alcoholic central nervous damage by suppressing microglia-mediated neuroinflammation and modulating the microbiome-gut-brain axis

Wei, H., Yu, C., Zhang, C., Ren, Y., Guo, L., Wang, T., Chen, F., Li, Y., Zhang, X., Wang, H., et al. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.114308 · Cited by 231 · see citing works

Tryptophan metabolism drives dynamic immunosuppressive myeloid states in IDH-mutant gliomas

Friedrich, M., Sankowski, R., Bunse, L., Kilian, M., Green, E., Guevara, C. R., Pusch, S., Poschet, G., Sanghvi, K., Hahn, M., et al. (2021) · Nature Cancer · doi:10.1038/s43018-021-00201-z · Cited by 232 · see citing works

Modulation of T cells by tryptophan metabolites in the kynurenine pathway

Stone, T. W., & Williams, R. O. (2023) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2023.04.006 · Cited by 229 · see citing works

Immunosuppressive IDO in Cancer: Mechanisms of Action, Animal Models, and Targeting Strategies

Zhai, L., Bell, A., Ladomersky, E., Lauing, K. L., Bollu, L. R., Sosman, J. A., Zhang, B., Wu, J. D., Miller, S. D., Meeks, J. J., et al. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.01185 · Cited by 222 · see citing works

Molecular hybridization: a powerful tool for multitarget drug discovery

Pinheiro, P. D. S. M., Franco, L. S., Montagnoli, T. L., & Fraga, C. A. M. (2024) · Expert Opinion on Drug Discovery · doi:10.1080/17460441.2024.2322990 · Cited by 224 · see citing works

Formate metabolism in health and disease

Pietzke, M., Meiser, J., & Vazquez, A. (2020) · Molecular Metabolism · doi:10.1016/j.molmet.2019.05.012 · Cited by 218 · see citing works

Gut microbiota-derived tryptophan metabolism mediates renal fibrosis by aryl hydrocarbon receptor signaling activation

Liu, J., Miao, H., Deng, D.-Q., Vaziri, N. D., Li, P., & Zhao, Y. (2020) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-020-03645-1 · Cited by 216 · see citing works

The multifaceted regulation of mitophagy by endogenous metabolites

Zhang, T., Liu, Q., Gao, W., Sehgal, S. A., & Wu, H. (2021) · Autophagy · doi:10.1080/15548627.2021.1975914 · Cited by 207 · see citing works

Metabolite interactions between host and microbiota during health and disease: Which feeds the other?

Zhang, Y., Chen, R., Zhang, D., Qi, S., & Liu, Y. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.114295 · Cited by 209 · see citing works

Human Anti-tumor Immunity: Insights from Immunotherapy Clinical Trials

Egen, J. G., Ouyang, W., & Wu, L. C. (2020) · Immunity · doi:10.1016/j.immuni.2019.12.010 · Cited by 197 · see citing works

Role of indoleamine 2,3-dioxygenase 1 (IDO1) and kynurenine pathway in the regulation of the aging process

Salminen, A. (2022) · Ageing Research Reviews · doi:10.1016/j.arr.2022.101573 · Cited by 197 · see citing works

Trial watch: IDO inhibitors in cancer therapy

Naour, J. L., Galluzzi, L., Zitvogel, L., Kroemer, G., & Vacchelli, E. (2020) · OncoImmunology · doi:10.1080/2162402x.2020.1777625 · Cited by 188 · see citing works

Functions of the aryl hydrocarbon receptor (AHR) beyond the canonical AHR/ARNT signaling pathway

Sondermann, N. C., Faßbender, S., Hartung, F., Hätälä, A. M., Rolfes, K. M., Vogel, C. F. A., & Haarmann‐Stemmann, T. (2022) · Biochemical Pharmacology · doi:10.1016/j.bcp.2022.115371 · Cited by 190 · see citing works

Molecular mechanisms and therapeutic significance of Tryptophan Metabolism and signaling in cancer

Yan, J. J., Chen, D., Ye, Z., Zhu, X., Li, X., Jiao, H., Duan, M., Zhang, C., Cheng, J., Xu, L., et al. (2024) · Molecular Cancer · doi:10.1186/s12943-024-02164-y · Cited by 184 · see citing works

Mechanisms of immune escape in the cancer immune cycle

Tang, S., Ning, Q., Yang, L., Mo, Z., & Tang, S. (2020) · International Immunopharmacology · doi:10.1016/j.intimp.2020.106700 · Cited by 183 · see citing works

Activating cGAS-STING pathway with ROS-responsive nanoparticles delivering a hybrid prodrug for enhanced chemo-immunotherapy

Cao, L., Tian, H., Fang, M., Xu, Z., Tang, D., Chen, J., Yin, J., Xiao, H., Shang, K., Han, H., et al. (2022) · Biomaterials · doi:10.1016/j.biomaterials.2022.121856 · Cited by 176 · see citing works

Dendritic cell maturation in cancer

Moon, C. Y., Belabed, M., Park, M. D., Mattiuz, R., Puleston, D. J., & Mérad, M. (2025) · Nature reviews. Cancer · doi:10.1038/s41568-024-00787-3 · Cited by 186 · see citing works

Is There a Clinical Future for IDO1 Inhibitors After the Failure of Epacadostat in Melanoma?

Van den Eynde, B. J., van Baren, N., & Baurain, J.-F. (2020) · Annual Review of Cancer Biology · doi:10.1146/annurev-cancerbio-030419-033635 · Cited by 175 · see citing works

The Role of Tryptophan Metabolites in Neuropsychiatric Disorders

Davidson, M., Rashidi, N., Nurgali, K., & Apostolopoulos, V. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23179968 · Cited by 180 · see citing works

A next-generation probiotic: Akkermansia muciniphila ameliorates chronic stress–induced depressive-like behavior in mice by regulating gut microbiota and metabolites

Ding, Y., Bu, F., Chen, T., Shi, G., Yuan, X., Feng, Z., Duan, Z., Wang, R., Zhang, S., Wang, Q., et al. (2021) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-021-11622-2 · Cited by 173 · see citing works

Inflammation-Induced Tryptophan Breakdown is Related With Anemia, Fatigue, and Depression in Cancer

Lanser, L., Kink, P., Egger, E. M., Willenbacher, W., Fuchs, D., Weiß, G., & Kurz, K. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.00249 · Cited by 172 · see citing works

Nutritional Support of Neurodevelopment and Cognitive Function in Infants and Young Children—An Update and Novel Insights

Kadosh, K. C., Muhardi, L., Parikh, P., Basso, M., Mohamed, H. J. J., Prawitasari, T., Samuel, F. O., Ma, G., & Geurts, J. M. W. (2021) · Nutrients · doi:10.3390/nu13010199 · Cited by 186 · see citing works

The gut vascular barrier: a new player in the gut–liver–brain axis

Brescia, P., & Rescigno, M. (2021) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2021.06.007 · Cited by 158 · see citing works

Gut–Brain Axis and Neuroinflammation: The Role of Gut Permeability and the Kynurenine Pathway in Neurological Disorders

Kearns, R. (2024) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-024-01496-z · Cited by 171 · see citing works

Physiology and Inflammation Driven Pathophysiology of Iron Homeostasis—Mechanistic Insights into Anemia of Inflammation and Its Treatment

Lanser, L., Fuchs, D., Kurz, K., & Weiß, G. (2021) · Nutrients · doi:10.3390/nu13113732 · Cited by 166 · see citing works

Host–microbiome interactions: the aryl hydrocarbon receptor as a critical node in tryptophan metabolites to brain signaling

Ma, N., He, T., Johnston, L. J., & Ma, X. (2020) · Gut Microbes · doi:10.1080/19490976.2020.1758008 · Cited by 158 · see citing works

The aryl hydrocarbon receptor and the gut–brain axis

Barroso, A., Mahler, J. V., Fonseca-Castro, P. H., & Quintana, F. J. (2021) · Cellular &amp; Molecular Immunology · doi:10.1038/s41423-020-00585-5 · Cited by 152 · see citing works

Bioactive NIR-II gold clusters for three-dimensional imaging and acute inflammation inhibition

Ma, H., Zhang, X., Liu, L., Huang, Y., Sun, S., Chen, K., Qi, X., Liu, P., Yan, Y., Wang, Y., et al. (2023) · Science Advances · doi:10.1126/sciadv.adh7828 · Cited by 151 · see citing works

The Tryptophan and Kynurenine Pathway Involved in the Development of Immune-Related Diseases

Tsuji, A., Ikeda, Y., Yoshikawa, S., Taniguchi, K., Sawamura, H., Morikawa, S., Nakashima, M., Asai, T. T., & Matsuda, S. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24065742 · Cited by 153 · see citing works

High-coverage metabolomics uncovers microbiota-driven biochemical landscape of interorgan transport and gut-brain communication in mice

Lai, Y., Liu, C., Yang, Y., Hsiao, Y.-C., Ru, H., & Lü, K. (2021) · Nature Communications · doi:10.1038/s41467-021-26209-8 · Cited by 144 · see citing works

Clinical development of metabolic inhibitors for oncology

Lemberg, K. M., Gori, S. S., Tsukamoto, T., Rais, R., & Slusher, B. S. (2022) · Journal of Clinical Investigation · doi:10.1172/jci148550 · Cited by 142 · see citing works

Tryptophan Metabolism in Central Nervous System Diseases: Pathophysiology and Potential Therapeutic Strategies

Huang, Y., Zhao, M., Chen, X., Zhang, R., Le, A., Hong, M., Zhang, Y., Jia, L., Zang, W., Jiang, C., et al. (2023) · Aging and disease · doi:10.14336/ad.2022.0916 · Cited by 138 · see citing works

The role of the indoles in microbiota-gut-brain axis and potential therapeutic targets: A focus on human neurological and neuropsychiatric diseases

Zhou, Y., Chen, Y., He, H., Peng, M., Zeng, M., & Sun, H. (2023) · Neuropharmacology · doi:10.1016/j.neuropharm.2023.109690 · Cited by 141 · see citing works

Emerging strategies in targeting tumor-resident myeloid cells for cancer immunotherapy

Wang, Y., Johnson, K. C. C., Gatti-Mays, M. E., & Li, Z. (2022) · Journal of Hematology & Oncology · doi:10.1186/s13045-022-01335-y · Cited by 135 · see citing works

Tryptophan‐derived serotonin‐kynurenine balance in immune activation and intestinal inflammation

Haq, S., Grondin, J. A., & Khan, W. I. (2021) · The FASEB Journal · doi:10.1096/fj.202100702r · Cited by 135 · see citing works

NAD metabolism: Role in senescence regulation and aging

Chini, C. C. S., Cordeiro, H. S., Tran, N. L. K., & Chini, E. N. (2023) · Aging Cell · doi:10.1111/acel.13920 · Cited by 138 · see citing works

Modulation of Macrophage Immunometabolism: A New Approach to Fight Infections

Gauthier, T., & Chen, W. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.780839 · Cited by 134 · see citing works

Adjunctive Probiotics Alleviates Asthmatic Symptoms via Modulating the Gut Microbiome and Serum Metabolome

Liu, A., Ma, T., Xu, N., Jin, H., Zhao, F., Kwok, L., Zhang, H., Zhang, S., & Sun, Z. (2021) · Microbiology Spectrum · doi:10.1128/spectrum.00859-21 · Cited by 132 · see citing works

Colonization and development of the gut microbiome in calves

Du, Y., Gao, Y., Hu, M., Hou, J., Yang, L., Wang, X., Du, W., Liu, J., & Xu, Q. (2023) · Journal of Animal Science and Biotechnology/Journal of animal science and biotechnology · doi:10.1186/s40104-023-00856-x · Cited by 129 · see citing works

The significant role of amino acid metabolic reprogramming in cancer

Liu, X., Ren, B., Ren, J., Gu, M., You, L., & Zhao, Y.-P. (2024) · Cell Communication and Signaling · doi:10.1186/s12964-024-01760-1 · Cited by 135 · see citing works

Kynurenine emerges from the shadows – Current knowledge on its fate and function

Marszałek‐Grabska, M., Walczak, K., Gaweł, K., Wicha-Komsta, K., Wnorowska, S., Wnorowski, A., & Turski, W. A. (2021) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2021.107845 · Cited by 126 · see citing works

Systemic tryptophan homeostasis

Klaessens, S., Stroobant, V., de Plaen, E., & den Eynde, B. V. (2022) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2022.897929 · Cited by 110 · see citing works

Targeted cancer immunotherapy with genetically engineered oncolytic Salmonella typhimurium

Guo, Y., Chen, Y., Liu, X., Min, J.-J., Tan, W., & Zheng, J. H. (2020) · Cancer Letters · doi:10.1016/j.canlet.2019.10.033 · Cited by 124 · see citing works

Spatial transcriptomics reveals tryptophan metabolism restricting maturation of intratumoral tertiary lymphoid structures

Tang, Z., Bai, Y., Fang, Q., Yuan, Y., Zeng, Q., Chen, S., Xu, T., Chen, J., Tan, L., Wang, C., et al. (2025) · Cancer Cell · doi:10.1016/j.ccell.2025.03.011 · Cited by 127 · see citing works

The lysine degradation pathway: Subcellular compartmentalization and enzyme deficiencies

Leandro, J., & Houten, S. M. (2020) · Molecular Genetics and Metabolism · doi:10.1016/j.ymgme.2020.07.010 · Cited by 122 · see citing works

Charge-specific adverse effects of polystyrene nanoplastics on zebrafish (Danio rerio) development and behavior

Teng, M., Zhao, X., Wu, F., Wang, C., Wang, C., White, J. C., Zhao, W., Zhou, L., Yan, S., & Tian, S. (2022) · Environment International · doi:10.1016/j.envint.2022.107154 · Cited by 120 · see citing works

Interferon-Induced IDO1 Mediates Radiation Resistance and Is a Therapeutic Target in Colorectal Cancer

Chen, B., Alvarado, D. M., Iticovici, M. S., Kau, N. S., Park, H., Parikh, P. J., Thotala, D. K., & Ciorba, M. A. (2020) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-19-0282 · Cited by 118 · see citing works

Metabolic Reprogramming in Anticancer Drug Resistance: A Focus on Amino Acids

Pranzini, E., Pardella, E., Paoli, P., Fendt, S., & Taddei, M. L. (2021) · Trends in cancer · doi:10.1016/j.trecan.2021.02.004 · Cited by 114 · see citing works

Investigating Casual Associations Among Gut Microbiota, Metabolites, and Neurodegenerative Diseases: A Mendelian Randomization Study

Ning, J., Huang, S., Chen, S.-D., Zhang, Y.-R., Huang, Y., & Yu, J. (2022) · Journal of Alzheimer s Disease · doi:10.3233/jad-215411 · Cited by 114 · see citing works

Kynurenic acid and cancer: facts and controversies

Walczak, K., Wnorowski, A., Turski, W. A., & Plech, T. (2019) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-019-03332-w · Cited by 115 · see citing works

Microbiota and cancer: host cellular mechanisms activated by gut microbial metabolites

Tsvetikova, S. A., & Koshel, E. I. (2020) · International Journal of Medical Microbiology · doi:10.1016/j.ijmm.2020.151425 · Cited by 111 · see citing works

Kynurenine pathway in Parkinson's disease—An update

Venkatesan, D., Iyer, M., Narayanasamy, A., Siva, K., & Vellingiri, B. (2020) · eNeurologicalSci · doi:10.1016/j.ensci.2020.100270 · Cited by 112 · see citing works

Tryptophan-rich diet ameliorates chronic unpredictable mild stress induced depression- and anxiety-like behavior in mice: The potential involvement of gut-brain axis

Wang, D., Wu, J., Zhu, P., Xie, H., Lu, L., Bai, W., Pan, W., Shi, R., Ye, J., Xia, B., et al. (2022) · Food Research International · doi:10.1016/j.foodres.2022.111289 · Cited by 112 · see citing works

Metformin Reprograms Tryptophan Metabolism to Stimulate CD8+ T-cell Function in Colorectal Cancer

Huang, X., Sun, T., Wang, J., Hong, X., Chen, H., Yan, T., Zhou, C., Sun, D., Yang, C. G., Yu, T., et al. (2023) · Cancer Research · doi:10.1158/0008-5472.can-22-3042 · Cited by 111 · see citing works

Chiral nanoparticle-remodeled gut microbiota alleviates neurodegeneration via the gut–brain axis

Guo, X. L., Li, C., Zhang, J., Sun, M., Xu, J., Xu, C., Kuang, H., & Xu, L. (2023) · Nature Aging · doi:10.1038/s43587-023-00516-9 · Cited by 110 · see citing works

Smart Nanosized Drug Delivery Systems Inducing Immunogenic Cell Death for Combination with Cancer Immunotherapy

Zhou, L., Zhang, P., Wang, H., Wang, D., & Li, Y. (2020) · Accounts of Chemical Research · doi:10.1021/acs.accounts.0c00254 · Cited by 108 · see citing works

An in situ hydrogel-mediated chemo-immunometabolic cancer therapy

Wang, B., Chen, J., Caserto, J. S., Wang, X., & Ma, M. (2022) · Nature Communications · doi:10.1038/s41467-022-31579-8 · Cited by 109 · see citing works

Tryptophan and its metabolites in normal physiology and cancer etiology

Perez‐Castro, L., Garcia, R., Venkateswaran, N., Barnes, S. D., & Conacci‐Sorrell, M. (2021) · FEBS Journal · doi:10.1111/febs.16245 · Cited by 104 · see citing works

High-fat diet-disturbed gut microbiota-colonocyte interactions contribute to dysregulating peripheral tryptophan-kynurenine metabolism

Sun, P., Wang, M., Liu, Y., Li, L., Chai, X., Zheng, W., Chen, S., Zhu, X., & Zhao, S. (2023) · Microbiome · doi:10.1186/s40168-023-01606-x · Cited by 109 · see citing works

Amino Acid Metabolism in Cancer Drug Resistance

Yoo, H.-C., & Han, J. M. (2022) · Cells · doi:10.3390/cells11010140 · Cited by 105 · see citing works

Gut flora disequilibrium promotes the initiation of liver cancer by modulating tryptophan metabolism and up-regulating SREBP2

Chen, W., Wen, L., Bao, Y., Tang, Z., Zhao, J., Zhang, X., Wei, T., Zhang, J., Ma, T., Zhang, Q., et al. (2022) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2203894119 · Cited by 105 · see citing works

Targeting Tryptophan Catabolism in Cancer Immunotherapy Era: Challenges and Perspectives

Peyraud, F., Guégan, J., Bodet, D., Cousin, S., Bessede, A., & Italiano, A. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.807271 · Cited by 130 · see citing works

Role of tryptophan metabolism in cancers and therapeutic implications

Liu, X., & Zhai, X. (2021) · Biochimie · doi:10.1016/j.biochi.2021.01.005 · Cited by 70 · see citing works

Cancer Immunotherapy by Targeting IDO1/TDO and Their Downstream Effectors

Platten, M., Doeberitz, N. V. K., Oezen, I., Wick, W., & Ochs, K. (2015) · Frontiers in Immunology · doi:10.3389/fimmu.2014.00673 · Cited by 342 · see citing works

Molecular Pathways: Targeting IDO1 and Other Tryptophan Dioxygenases for Cancer Immunotherapy

Zhai, L., Spranger, S., Binder, D. C., Gritsina, G., Lauing, K. L., Giles, F. J., & Wainwright, D. A. (2015) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-15-0420 · Cited by 325 · see citing works

Targeting the Broadly Pathogenic Kynurenine Pathway

(2015) · Thammasat University Digital Collections